• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于无机纳米粒子的 T1 和 T1/T2 磁共振对比探针。

Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.

机构信息

College of Chemistry, Beijing Normal University, Beijing 100875, China.

出版信息

Nanoscale. 2012 Oct 21;4(20):6235-43. doi: 10.1039/c2nr31865b.

DOI:10.1039/c2nr31865b
PMID:22971876
Abstract

Magnetic resonance imaging (MRI) yields high spatially resolved contrast with anatomical details for diagnosis, deeper penetration depth and rapid 3D scanning. To improve imaging sensitivity, adding contrast agents accelerates the relaxation rate of water molecules, thereby greatly increasing the contrast between specific issues or organs of interest. Currently, the majority of T(1) contrast agents are paramagnetic molecular complexes, typically Gd(iii) chelates. Various nanoparticulate T(1) and T(1)/T(2) contrast agents have recently been investigated as novel agents possessing the advantages of both the T(1) contrast effect and nanostructural characteristics. In this minireview, we describe the recent progress of these inorganic nanoparticle-based MRI contrast agents. Specifically, we mainly report on Gd and Mn-based inorganic nanoparticles and ultrasmall iron oxide/ferrite nanoparticles.

摘要

磁共振成像(MRI)具有高空间分辨率对比度和解剖细节,可用于诊断,具有更深的穿透深度和快速的 3D 扫描。为了提高成像灵敏度,添加造影剂会加速水分子的弛豫率,从而大大增加特定问题或感兴趣器官之间的对比度。目前,大多数 T(1)造影剂是顺磁分子配合物,通常为 Gd(iii)螯合物。最近,人们研究了各种纳米颗粒 T(1)和 T(1)/T(2)造影剂作为新型造影剂,兼具 T(1)造影效果和纳米结构特性的优势。在这篇综述中,我们描述了这些基于无机纳米粒子的 MRI 造影剂的最新进展。具体而言,我们主要报告基于 Gd 和 Mn 的无机纳米粒子以及超小的氧化铁/铁氧体纳米粒子。

相似文献

1
Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.基于无机纳米粒子的 T1 和 T1/T2 磁共振对比探针。
Nanoscale. 2012 Oct 21;4(20):6235-43. doi: 10.1039/c2nr31865b.
2
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.推动基于镧系元素的磁共振成像(MRI)造影剂在分子成像应用中的灵敏度极限。
Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p.
3
Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.用于 T1 和 T2 加权磁共振成像双对比的超小聚乙二醇化氧化铁纳米粒子的简便合成。
Nanotechnology. 2011 Jun 17;22(24):245604. doi: 10.1088/0957-4484/22/24/245604. Epub 2011 Apr 21.
4
Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.聚乙二醇化 Gd2O3 纳米颗粒的合成与表征及其在 MRI 对比增强中的应用。
Langmuir. 2010 Apr 20;26(8):5753-62. doi: 10.1021/la903566y.
5
Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.超小水溶性金属-氧化铁纳米颗粒作为磁共振成像的 T1 加权造影剂。
Phys Chem Chem Phys. 2012 Feb 28;14(8):2631-6. doi: 10.1039/c2cp23196d. Epub 2012 Jan 25.
6
Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.使用多功能钆标记超顺磁氧化铁纳米颗粒对肿瘤进行靶向双重对比 T1 和 T2 加权磁共振成像。
Biomaterials. 2011 Jul;32(20):4584-93. doi: 10.1016/j.biomaterials.2011.03.018. Epub 2011 Mar 31.
7
Contrast agents: magnetic resonance.造影剂:磁共振成像
Handb Exp Pharmacol. 2008(185 Pt 1):135-65. doi: 10.1007/978-3-540-72718-7_7.
8
Contrast agents for MRI.磁共振成像对比剂。
Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):4485-97. doi: 10.1016/j.msec.2013.07.012. Epub 2013 Jul 18.
9
Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.磁共振成像(MRI)对比剂用于肿瘤诊断。
J Healthc Eng. 2013;4(1):23-45. doi: 10.1260/2040-2295.4.1.23.
10
Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.PEG 化超小氧化钆纳米颗粒的快速合成及其用于细胞标记和 MRI 示踪。
ACS Appl Mater Interfaces. 2012 Sep 26;4(9):4506-15. doi: 10.1021/am3006466. Epub 2012 Aug 17.

引用本文的文献

1
Current Status and Future Aspects of Gadolinium Oxide Nanoparticles as Positive Magnetic Resonance Imaging Contrast Agents.氧化钆纳米颗粒作为阳性磁共振成像造影剂的现状与未来展望
Nanomaterials (Basel). 2025 Sep 1;15(17):1340. doi: 10.3390/nano15171340.
2
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.基于磁共振成像的肿瘤诊断与治疗一体化纳米诊疗剂的最新进展
Int J Nanomedicine. 2025 Aug 29;20:10503-10540. doi: 10.2147/IJN.S529003. eCollection 2025.
3
Precise air oxidation for continuous production of superparamagnetic FeO nanoparticles at room temperature through a microfilm reactor.
通过微膜反应器在室温下进行精确空气氧化以连续生产超顺磁性FeO纳米颗粒。
RSC Adv. 2024 Oct 29;14(46):34320-34327. doi: 10.1039/d4ra05373g. eCollection 2024 Oct 23.
4
Plasmonic gadolinium oxide nanomatryoshkas: bifunctional magnetic resonance imaging enhancers for photothermal cancer therapy.等离子体氧化钆纳米套娃:用于光热癌症治疗的双功能磁共振成像增强剂。
PNAS Nexus. 2022 Jul 29;1(4):pgac140. doi: 10.1093/pnasnexus/pgac140. eCollection 2022 Sep.
5
Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects.用于癌症治疗的智能多功能磁性纳米颗粒:临床挑战与未来前景
Nanomaterials (Basel). 2022 Oct 12;12(20):3567. doi: 10.3390/nano12203567.
6
Synthesis and preclinical application of a Prussian blue-based dual fluorescent and magnetic contrast agent (CA).普鲁士蓝基双荧光和磁共振对比剂(CA)的合成及初步临床应用。
PLoS One. 2022 Jul 20;17(7):e0264554. doi: 10.1371/journal.pone.0264554. eCollection 2022.
7
Aptamers used for molecular imaging and theranostics - recent developments.适体在分子影像和治疗诊断学中的应用——最新进展。
Theranostics. 2022 May 13;12(9):4010-4050. doi: 10.7150/thno.72949. eCollection 2022.
8
Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks.从医学进步到健康和生态风险看镧系元素的利弊。
Molecules. 2020 Dec 7;25(23):5762. doi: 10.3390/molecules25235762.
9
Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer.负载超顺磁性氧化铁和铁的唾液酸工程化介孔聚多巴胺纳米粒子作为一种新型诊疗剂用于T1/T2双模态磁共振成像引导下的肝癌联合化疗-光热治疗
Bioact Mater. 2020 Nov 10;6(5):1423-1435. doi: 10.1016/j.bioactmat.2020.10.020. eCollection 2021 May.
10
The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances.肾脏可清除磁共振成像对比剂:现状与最新进展。
Molecules. 2020 Nov 1;25(21):5072. doi: 10.3390/molecules25215072.